A potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumour cells in ...

The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...

Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral CSF1R inhibitor vimseltinib, newly branded Romvimza, could take significant ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...

Typically this would be spread out over a year, but thanks to advances in surgical precision and 3D printing, can be ...

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent ...